In the current study we explore autoreactivity to different PTMs in individuals at risk of developing RA and early RA patients, and provide a comprehensive summary of how different IgG and IgA autoreactivities are related and how the multireactivity profiles can define patient subsets. Here, CD79A is linked to rheumatoid arthritis.